Literature DB >> 26365194

Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells.

Christopher Dravis1, Benjamin T Spike1, J Chuck Harrell2, Claire Johns1, Christy L Trejo1, E Michelle Southard-Smith3, Charles M Perou4, Geoffrey M Wahl5.   

Abstract

To discover mechanisms that mediate plasticity in mammary cells, we characterized signaling networks that are present in the mammary stem cells responsible for fetal and adult mammary development. These analyses identified a signaling axis between FGF signaling and the transcription factor Sox10. Here, we show that Sox10 is specifically expressed in mammary cells exhibiting the highest levels of stem/progenitor activity. This includes fetal and adult mammary cells in vivo and mammary organoids in vitro. Sox10 is functionally relevant, as its deletion reduces stem/progenitor competence whereas its overexpression increases stem/progenitor activity. Intriguingly, we also show that Sox10 overexpression causes mammary cells to undergo a mesenchymal transition. Consistent with these findings, Sox10 is preferentially expressed in stem- and mesenchymal-like breast cancers. These results demonstrate a signaling mechanism through which stem and mesenchymal states are acquired in mammary cells and suggest therapeutic avenues in breast cancers for which targeted therapies are currently unavailable.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26365194      PMCID: PMC4591253          DOI: 10.1016/j.celrep.2015.08.040

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

1.  Distinct stem cells contribute to mammary gland development and maintenance.

Authors:  Alexandra Van Keymeulen; Ana Sofia Rocha; Marielle Ousset; Benjamin Beck; Gaëlle Bouvencourt; Jason Rock; Neha Sharma; Sophie Dekoninck; Cédric Blanpain
Journal:  Nature       Date:  2011-10-09       Impact factor: 49.962

2.  SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Authors:  Saskia A Graf; Christian Busch; Anja-Katrin Bosserhoff; Robert Besch; Carola Berking
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

3.  Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function.

Authors:  Adam C Pond; Xue Bin; Torey Batts; Kevin Roarty; Susan Hilsenbeck; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

4.  Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.

Authors:  Ashley Cimino-Mathews; Andrea P Subhawong; Hillary Elwood; Hind Nassar Warzecha; Rajni Sharma; Ben Ho Park; Janis M Taube; Peter B Illei; Pedram Argani
Journal:  Hum Pathol       Date:  2012-12-20       Impact factor: 3.466

5.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

6.  Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo.

Authors:  Arnaud André Mailleux; Bradley Spencer-Dene; Christian Dillon; Delphine Ndiaye; Catherine Savona-Baron; Nobuyuki Itoh; Shigeaki Kato; Clive Dickson; Jean Paul Thiery; Saverio Bellusci
Journal:  Development       Date:  2002-01       Impact factor: 6.868

7.  SOX10 directly modulates ERBB3 transcription via an intronic neural crest enhancer.

Authors:  Megana K Prasad; Xylena Reed; David U Gorkin; Julia C Cronin; Anthony R McAdow; Kristopher Chain; Chani J Hodonsky; Erin A Jones; John Svaren; Anthony Antonellis; Stephen L Johnson; Stacie K Loftus; William J Pavan; Andrew S McCallion
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

8.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

9.  Mammary stem cells have myoepithelial cell properties.

Authors:  Michael D Prater; Valérie Petit; I Alasdair Russell; Rajshekhar R Giraddi; Mona Shehata; Suraj Menon; Reiner Schulte; Ivo Kalajzic; Nicola Rath; Michael F Olson; Daniel Metzger; Marisa M Faraldo; Marie-Ange Deugnier; Marina A Glukhova; John Stingl
Journal:  Nat Cell Biol       Date:  2014-08-31       Impact factor: 28.824

Review 10.  The mammary cellular hierarchy and breast cancer.

Authors:  Samantha R Oakes; David Gallego-Ortega; Christopher J Ormandy
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

View more
  53 in total

1.  p21CIP1 Promotes Mammary Cancer-Initiating Cells via Activation of Wnt/TCF1/CyclinD1 Signaling.

Authors:  Outhiriaradjou Benard; Xia Qian; Huizhi Liang; Zuen Ren; Kimita Suyama; Larry Norton; Rachel B Hazan
Journal:  Mol Cancer Res       Date:  2019-04-09       Impact factor: 5.852

Review 2.  Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasis.

Authors:  M U J Oliphant; Deguang Kong; Hengbo Zhou; M T Lewis; H L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-04-22       Impact factor: 2.673

3.  MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.

Authors:  Alex Panaccione; Yi Zhang; Molly Ryan; Christopher A Moskaluk; Karen S Anderson; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Stem Cell Res       Date:  2017-05-05       Impact factor: 2.020

4.  Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.

Authors:  Alex Panaccione; Yan Guo; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Clin Breast Cancer       Date:  2017-01-27       Impact factor: 3.225

5.  Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity.

Authors:  Christopher Dravis; Chi-Yeh Chung; Nikki K Lytle; Jaslem Herrera-Valdez; Gidsela Luna; Christy L Trejo; Tannishtha Reya; Geoffrey M Wahl
Journal:  Cancer Cell       Date:  2018-08-30       Impact factor: 31.743

Review 6.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

7.  Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors.

Authors:  Nevena B Ognjenovic; Meisam Bagheri; Gadisti Aisha Mohamed; Ke Xu; Youdinghuan Chen; Mohamed Ashick Mohamed Saleem; Meredith S Brown; Shivashankar H Nagaraj; Kristen E Muller; Scott A Gerber; Brock C Christensen; Diwakar R Pattabiraman
Journal:  Dev Cell       Date:  2020-10-28       Impact factor: 12.270

8.  Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma.

Authors:  Marin Kato; Hiroshi Nishihara; Hideyuki Hayashi; Taichi Kimura; Yusuke Ishida; Lei Wang; Masumi Tsuda; Mishie Ann Tanino; Shinya Tanaka
Journal:  Med Oncol       Date:  2016-12-10       Impact factor: 3.064

9.  WNT-Mediated Regulation of FOXO1 Constitutes a Critical Axis Maintaining Pubertal Mammary Stem Cell Homeostasis.

Authors:  Amulya Sreekumar; Michael J Toneff; Eajer Toh; Kevin Roarty; Chad J Creighton; George K Belka; Dong-Kee Lee; Jianming Xu; Lewis A Chodosh; JoAnne S Richards; Jeffrey M Rosen
Journal:  Dev Cell       Date:  2017-11-02       Impact factor: 12.270

10.  Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma.

Authors:  Aparna Harbhajanka; Satyapal Chahar; Kristy Miskimen; Paula Silverman; Lyndsay Harris; Nicole Williams; Vinay Varadan; Hannah Gilmore
Journal:  Hum Pathol       Date:  2018-06-09       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.